Edal, Baby Boy .

HRN: 24-67-84  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2024
04/01/2024
IV
52 Mg LD Then 26mg Maintenance
Q 8 Hours
Meconium Aspiration Syndrome
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: